The author discusses a report released by Sen. Ron Johnson (R-Wis.), which highlights how federal health agencies allegedly downplayed the risks of myocarditis and other adverse events associated with COVID-19 vaccines. The author argues that the report contains evidence of government actions that minimized the risks of these vaccines, specifically myocarditis, despite concerns and data showing potential harm. The author also critiques how the pandemic was handled, particularly regarding lockdowns, treatment protocols, and the dismissal of alternative treatments like Hydroxychloroquine (HCQ) and ivermectin.
The author suggests that the COVID-19 pandemic created a massive wealth transfer and that pharmaceutical companies, the government, and legacy media were part of a coordinated effort to promote vaccines and discredit alternative treatments. In this narrative, HCQ and ivermectin, both used as treatments for COVID-19 by various doctors worldwide, were unjustly criticized and restricted by health authorities. This was framed as an effort to pave the way for Emergency Use Authorizations (EUAs) of the COVID-19 vaccines, which became a profitable avenue for pharmaceutical companies.
The underlying argument posits that the government, the media, and pharmaceutical companies prioritized financial interests over public health, leading to the suppression of viable treatments in favor of experimental vaccines.
Sen. Ron Johnson’s Report:
Released a report titled “Failure to Warn” focused on federal agencies downplaying myocarditis risks from COVID-19 vaccines.
The report claims evidence of the Biden administration delaying public warnings about vaccine risks.
Government and COVID Response:
The pandemic triggered massive economic disruptions, including lockdowns that affected businesses and jobs.
NIH initially recommended ventilators and oxygen therapy for COVID patients, which were later shown to be ineffective and damaging.
Government and medical authorities failed to adjust their recommendations despite mounting evidence of the ineffectiveness of early protocols.
Hydroxychloroquine (HCQ) Controversy:
HCQ was used successfully by doctors like Dr. Zelenko and Dr. Stephen Smith to treat COVID early on, with positive results (zero deaths, zero hospitalizations).
Despite this, the FDA and NIH dismissed HCQ as ineffective and risky, preventing widespread use.
The Association of American Physicians and Surgeons (AAPS) filed a lawsuit to release HCQ for broader use.
Ivermectin Disinformation:
Ivermectin, a widely used antiparasitic, was also touted by many doctors as an effective early COVID treatment.
The FDA issued multiple warnings against its use, citing lack of evidence and potential risks, while media outlets disparaged it, calling it a "horse dewormer."
Despite the warnings, doctors like Dr. Pierre Kory and others reported significant success in treating patients with ivermectin.
Government and Media’s Discrediting of Alternatives:
The media and government actively criticized the use of HCQ and ivermectin, even as reports of their success mounted.
Prominent figures like President Trump and Joe Rogan faced media scrutiny for using these drugs.
Emergency Use Authorization (EUA) and Big Pharma:
The author argues that the EUA for COVID vaccines required the discrediting of alternative treatments like HCQ and ivermectin.
The pharmaceutical industry, benefiting from billions in government funding for vaccine production, was incentivized to block treatments that could compete with the vaccine market.
The FDA’s EUA process for COVID vaccines essentially prohibited the use of existing, cheaper treatments in favor of experimental vaccines, which could generate massive profits for pharmaceutical companies.
Financial Interests and “Follow the Money”:
The pandemic response is described as one of the largest involuntary wealth transfers in history, suggesting that financial motivations underpinned much of the government’s health policies.
The author calls attention to the role of money in shaping the narrative around COVID treatments and vaccines.
Key Takeaways:
Alternative treatments like HCQ and ivermectin were effective for many, but were suppressed by government agencies and media.
The Emergency Use Authorization process for vaccines required dismissing all alternatives to create a market for experimental vaccines.
The financial aspect of the pandemic response is highlighted, suggesting that pharmaceutical companies stood to profit by blocking effective but inexpensive treatments.
Media bias is shown to have played a role in shaping public opinion and discouraging the use of alternative treatments, despite evidence of their success.
No comments:
Post a Comment